Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age

Drugs and Aging - United Kingdom
doi 10.1007/s40266-020-00753-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

(451) Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis

Journal of Pain
NeurologyAnesthesiologyPain Medicine
2014English

Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients With Chronic Noncancer Pain

Pain Practice
AnesthesiologyPain Medicine
2017English

(479) a Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Single Ascending-Dose Study to Evaluate the Safety and Efficacy of Naldemedine in Patients With Chronic Non-Cancer Pain and Opioid-Induced Bowel Dysfunction

Journal of Pain
NeurologyAnesthesiologyPain Medicine
2016English

Safety and Efficacy of the Unique Opioid Buprenorphine for the Treatment of Chronic Pain

Journal of Pain Research
AnesthesiologyPain Medicine
2019English

Tapering Off Long-Term Opioid Therapy in Chronic Non-Cancer Pain Patients: A Randomized Clinical Trial

European Journal of Pain
MedicineAnesthesiologyPain Medicine
2018English

Cross Validation of the Current Opioid Misuse Measure to Monitor Chronic Pain Patients on Opioid Therapy

Clinical Journal of Pain
NeurologyAnesthesiologyPain Medicine
2010English

Opioid Therapy for Chronic Pain

New England Journal of Medicine
Medicine
2003English

Incidence and Health Related Quality of Life of Opioid-Induced Constipation in Chronic Noncancer Pain Patients: A Prospective Multicentre Cohort Study

Pain Research and Treatment
NeurologyAnesthesiologyPain Medicine
2018English

The Role of Opioid Analgesics in the Treatment of Pain in Cancer Patients

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy